Target intelligence / Profile preview

Transmembrane protein 115 (TMEM115)

Target
TMEM115
Molecular classification
Other (integral membrane protein, specifically of the Golgi complex)
01

Overview

Transmembrane protein 115 (TMEM115) is an integral membrane protein primarily localized to the Golgi complex, where it regulates Golgi-to-endoplasmic reticulum (ER) retrograde transport[1][2][3][4]. TMEM115 contains four candidate transmembrane domains primarily in its N-terminal region and features cytoplasmic N- and C-terminal domains, with the C-terminal region exposed to the cytoplasm[1][2]. Functionally, TMEM115 interacts with components of the conserved oligomeric Golgi (COG) complex and COPI, and it may form homo-oligomers or dimers. The region immediately distal to the fourth transmembrane domain (residues 206–229) is both necessary and sufficient for Golgi targeting[1]. TMEM115 knockdown or overexpression disrupts Golgi-to-ER retrograde transport, altering O-linked glycosylation patterns and potentially impacting glycosylation enzyme distribution via trafficking defects[1][2][3]. TMEM115 expression is dysregulated in some cancers and metabolic disorders, although it is not established as a therapeutic target or known drug target.

Other names
PL6LUCA11.2Placental protein 6Protein PL6PP6testicular tissue protein Li 201TMEM115
02

Biological functions

Retrograde vesicle-mediated transport (Golgi to endoplasmic reticulum)Protein glycosylation regulationProtein bindingGolgi complex organization
03

Disease associations

Congenital disorder of glycosylation (potential, as a candidate in the CDG-plus group)Cancer (altered expression in certain cancers such as breast cancer and renal cell carcinoma; role is cell-type dependent)
04

Biomarkers

Changes in TMEM115 expression correlate with invasive breast cancer cell propertiespossible association with glycosylation status in rare metabolic or congenital disorders

Beyond the preview

Go deeper on Transmembrane protein 115 (TMEM115).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Transmembrane protein 115 (TMEM115).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call